BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 2, 2021
View Archived Issues
Recombinant HA stably presented on immunogenic liposomes improves immunogenicity in animal models
Read More
Discovery of a novel calcitonin gene-related peptide receptor antagonist azepinone series
Read More
Targeting hypoxia-induced metastatic genes shows therapeutic potential in uveal melanoma
Read More
FDA clears IND for phase I study of Protollin as treatment of AD
Read More
New glucocorticoid receptor modulators identified at Medshine Discovery
Read More
DNA-dependent protein kinase inhibitors discovered at Chengdu Baiyu Pharmaceutical
Read More
Enyo reports promising phase II data for vonafexor in patients with chronic hepatitis B
Read More
Beijing Kang Dini Pharmaceutical presents new IL-8 expression inhibitors
Read More
Jiangsu Simcere Pharmaceutical R&D discovers MAT2A inhibitors
Read More
Deuterated GC-376 variants show efficacy in model of SARS-CoV-2 infection
Read More
Addition of GEN-1 to standard NAC shows safety and efficacy in phase I ovarian cancer study
Read More
Changes in SavaDx and plasma P-tau181 confirm treatment effect of simufilam in AD
Read More
RemeGen receives Australian ethics approval for phase I trial of ADC RC-118
Read More
Topline phase II data with Sarconeos in sarcopenia
Read More
Evolutionary modeling warns of COVID-19 vaccine resistance
Read More
Trk-A inhibitor E-2511 restores cholinergic neurons in transgenic models of Alzheimer's disease
Read More
Lundbeck studies Lu-AG-06466 in phase I for fibromyalgia
Read More
Lundbeck opens phase I study of Lu-AG-09222 in headache model
Read More
China NMPA accepts IND for phase I study of CAN-103 for Gaucher's disease
Read More
U.K. MHRA clears initiation of first-in-human study of HMBD-001 in advanced cancers
Read More
